Medinet, Tokyo Univ', Shin-Yokohama Med Clinic Launch Clinical Studies Of Activated Self Gamma-delta T Cell Therapy For Non-Small Cell Lung Cancer
Main Category: Lung CancerArticle Date: 04 Mar 2006 - 6:00 PDT
email to a friend 
printer friendly 
view / write opinions
Current Article Ratings:
| Patient / Public: |  |
|
| Health Professional: |  |
1 (1 votes) |
| Article Opinions: | 0 posts |
Tokyo (JCN) - Medinet has signed a joint research agreement with the University of Tokyo and Shin-Yokohama Medical Clinic.
Under the terms of the agreement, the three partners will jointly undertake through March 2007 clinical studies of activated self gamma-delta T cell therapy, in which they aim to verify the safety and effectiveness of the therapy against non-small cell lung cancer.
The studies are designed for 10 patients who were treated for lung cancer at the University of Tokyo hospital. Through these means, Medinet aims to establish a new cancer therapy at the earliest date possible.
By Aki Tsukioka, JCN Staff Writer
Copyright © 2006 JCN. All rights reserved. A division of Japan Corporate News Network KK
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Lung Cancer headlines email to a friend printer friendly version
weekly newsletter daily news alerts
personalize your news
rss feeds
back to top
Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2010 MediLexicon International Ltd |
